Amedeo Smart

Free Medical Literature Service



Liver Diseases

  Free Subscription

Articles published in
Dig Dis Sci
    September 2022
  1. CHAPIN SE, Goldberg DS, Kaplan DE, Mahmud N, et al
    External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.
    Dig Dis Sci. 2022;67:4581-4589.
    >> Share

    August 2022
    Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Aug 10. pii: 10.1007/s10620-022-07644.
    >> Share

  3. SAKANO Y, Noda T, Kobayashi S, Kitagawa A, et al
    Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA.
    Dig Dis Sci. 2022;67:3817-3830.
    >> Share

  4. SOBOTKA LA, Esteban J, Volk ML, Elmunzer BJ, et al
    Acute Liver Injury in Patients Hospitalized with COVID-19.
    Dig Dis Sci. 2022;67:4204-4214.
    >> Share

  5. RAJAK S, Raza S, Tewari A, Sinha RA, et al
    Environmental Toxicants and NAFLD: A Neglected yet Significant Relationship.
    Dig Dis Sci. 2022;67:3497-3507.
    >> Share

    July 2022
  6. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
    >> Share

    Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR.
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07623.
    >> Share

    Hepatocellular Carcinoma in Hemochromatosis: Where or When?
    Dig Dis Sci. 2022 Jul 11. pii: 10.1007/s10620-022-07609.
    >> Share

  9. NATARAJAN Y, Patel P, Chu J, Yu X, et al
    Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07602.
    >> Share

  10. IZZY M, VanWagner LB
    Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07580.
    >> Share

  11. YARRA P, Dunn W, Younossi Z, Kuo YF, et al
    Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.
    Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07591.
    >> Share

  12. RAMAI D, Facciorusso A, Singh J, Brooks OW, et al
    Endoscopic Management of Ampullary Adenomas in Familial Adenomatous Polyposis Syndrome: A Systematic Review with Pooled Analysis.
    Dig Dis Sci. 2022;67:3220-3227.
    >> Share

  13. ELFEKI MA, Robles J, Akhtar Z, Ullah F, et al
    Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:3333-3339.
    >> Share

  14. FUNG BM, Leon DJ, Beck LN, Tabibian JH, et al
    Pre-procedural Preparation and Sedation for Gastrointestinal Endoscopy in Patients with Advanced Liver Disease.
    Dig Dis Sci. 2022;67:2739-2753.
    >> Share

  15. GARCIA CC, Piotrkowski B, Baz P, Poncino D, et al
    A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:3006-3016.
    >> Share

  16. THOMAIDES-BREARS HB, Alkhouri N, Allende D, Harisinghani M, et al
    Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022;67:3366-3394.
    >> Share

    June 2022
  17. DIJOSEPH K, Thorp A, Harrington A, Schmitz KH, et al
    Physical Activity and Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022 Jun 29. pii: 10.1007/s10620-022-07601.
    >> Share

  18. VIJAYARAGHAVAN R, Sarin SK, Bharadwaj A, Anand L, et al
    Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months.
    Dig Dis Sci. 2022 Jun 28. pii: 10.1007/s10620-022-07596.
    >> Share

  19. CHU J, Cholankeril G, Yu X, Rana A, et al
    Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC).
    Dig Dis Sci. 2022 Jun 27. pii: 10.1007/s10620-022-07565.
    >> Share

  20. OHNO A, Fujimori N, Kaku T, Takamatsu Y, et al
    Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07555.
    >> Share

  21. DHIR V, Bale A
    EUS-Guided Hepatico-Gastrostomy: To Dilate or Not to Dilate?
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07560.
    >> Share

  22. KUGELMAS M, Zapata I, Tawil J, Pessetto A, et al
    Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
    Dig Dis Sci. 2022 Jun 7. pii: 10.1007/s10620-022-07561.
    >> Share

  23. PAN AY, Zilberstein NF, Farnan JM, McConville JF, et al
    Recently Graduated Medical Students Lack Exposure to and Comfort with Chronic Liver Diseases.
    Dig Dis Sci. 2022;67:2081-2085.
    >> Share

  24. TESTINO G, Vignoli T, Patussi V, Allosio P, et al
    Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).
    Dig Dis Sci. 2022;67:1975-1986.
    >> Share

  25. GLASS L, Asefa H, Volk M, Lok AS, et al
    Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.
    Dig Dis Sci. 2022;67:2123-2133.
    >> Share

  26. NABI O, Boursier J, Lacombe K, Mathurin P, et al
    Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
    Dig Dis Sci. 2022;67:2584-2593.
    >> Share

  27. SIDDIQUI MA, Suresh S, Simmer S, Abu-Ghanimeh M, et al
    Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury.
    Dig Dis Sci. 2022;67:2577-2583.
    >> Share

    May 2022
  28. ASOTIBE JC, Banini BA
    Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07523.
    >> Share

  29. OSMAN KT, Abdelfattah AM, Mahmood SK, Elkhabiry L, et al
    Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07522.
    >> Share

  30. AL-OBAID LN, Bazarbashi AN, Ryou M
    Variceal Bleeding: Beyond Banding.
    Dig Dis Sci. 2022;67:1442-1454.
    >> Share

    April 2022
  31. B HADI Y, Khan RS, Lakhani DA, Khan AY, et al
    Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07481.
    >> Share

  32. ZHAO M, Ma L, Honda T, Kato A, et al
    Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet.
    Dig Dis Sci. 2022 Apr 10. pii: 10.1007/s10620-022-07489.
    >> Share

  33. NOBARANI S, Alaei-Shahmiri F, Aghili R, Malek M, et al
    Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Dig Dis Sci. 2022;67:1389-1398.
    >> Share

  34. NOUREDDIN N, Noureddin M, Singh A, Alkhouri N, et al
    Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.
    Dig Dis Sci. 2022;67:1379-1388.
    >> Share

    March 2022
  35. TAKIGAWA A, Sakamori R, Tahata Y, Yoshioka T, et al
    Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller.
    Dig Dis Sci. 2022 Mar 30. pii: 10.1007/s10620-022-07455.
    >> Share

  36. BUCSICS T, Lampichler K, Vierziger C, Schoder M, et al
    Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
    Dig Dis Sci. 2022 Mar 17. pii: 10.1007/s10620-022-07443.
    >> Share

  37. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    >> Share

  38. CHOI AY, Chang KJ, Samarasena JB, Lee JG, et al
    Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis.
    Dig Dis Sci. 2022 Mar 12. pii: 10.1007/s10620-022-07418.
    >> Share

  39. LEE TH, Hirshman N, Cardona DM, Berg CL, et al
    LR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions.
    Dig Dis Sci. 2022 Mar 7. pii: 10.1007/s10620-022-07428.
    >> Share

  40. ZHAO Z, Gao J, Huang S
    LncRNA SNHG7 Promotes the HCC Progression Through miR-122-5p/FOXK2 Axis.
    Dig Dis Sci. 2022;67:925-935.
    >> Share

  41. BHURWAL A, Makar M, Patel A, Mutneja H, et al
    Safety and Efficacy of Thrombin for Bleeding Gastric Varices: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022;67:953-963.
    >> Share

    February 2022
  42. DIBATTISTA JV, Burkholder DA, Lok AS, Chen VL, et al
    Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort.
    Dig Dis Sci. 2022 Feb 15. pii: 10.1007/s10620-022-07415.
    >> Share

  43. SINGH AD, Ford A, Lyu R, Layoun H, et al
    Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.
    Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07412.
    >> Share

  44. ROGAL SS, Chinman MJ, DeMonte W, Gibson S, et al
    Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.
    Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-022-07380.
    >> Share

  45. SHENOY A, Louissaint J, Shannon C, Tapper EB, et al
    Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis.
    Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-021-07376.
    >> Share

  46. JINDAL A, Sarin SK, Kumar M, Kumar G, et al
    Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient
    Dig Dis Sci. 2022 Feb 3. pii: 10.1007/s10620-021-07334.
    >> Share

  47. GIBBS JT, Louissaint J, Tapper EB
    Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma.
    Dig Dis Sci. 2022 Feb 2. pii: 10.1007/s10620-022-07400.
    >> Share

  48. FAUST A, Stine JG
    Time to Step It Up: Mobile Health Intervention for Lifestyle Modification in Patients with Nonalcoholic Fatty Liver Disease.

    Dig Dis Sci. 2022;67:403-405.
    >> Share

  49. CHAUHAN M, Singh K, Thuluvath PJ
    Bariatric Surgery in NAFLD.
    Dig Dis Sci. 2022;67:408-422.
    >> Share

  50. TINCOPA MA, Lyden A, Wong J, Jackson EA, et al
    Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:481-491.
    >> Share

  51. LI Y, Chen C, Lu L, Guo W, et al
    Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife.
    Dig Dis Sci. 2022;67:689-696.
    >> Share

    January 2022
  52. GONZALEZ JJ, Dziwis J, Patel YA, Tapper EB, et al
    Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study.
    Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07367.
    >> Share

  53. PARK MK, Lee YB, Moon H, Choi NR, et al
    Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation.
    Dig Dis Sci. 2022 Jan 20. pii: 10.1007/s10620-021-07365.
    >> Share

  54. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
    Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
    >> Share

  55. CHANDAN S, Deliwala S, Khan SR, Ramai D, et al
    Advanced Endoscopic Resection Techniques in Cirrhosis-A Systematic Review and Meta-Analysis of Outcomes.
    Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07364.
    >> Share

  56. WEGERMANN K, Wilder JM, Parish A, Niedzwiecki D, et al
    Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19.
    Dig Dis Sci. 2022;67:93-99.
    >> Share

  57. WAHID N, Rosenblatt R
    Disparities in Telehealth for Liver Disease: Revealing What Was Hidden in Plain Sight.
    Dig Dis Sci. 2022;67:3-5.
    >> Share

  58. NAJAFIAN N, Weber AT, Zuckerman JE, Zhang S, et al
    AL Lambda Amyloidosis Activates Acute Liver Failure in the Absence of Plasma Cell Dyscrasia.
    Dig Dis Sci. 2022;67:67-70.
    >> Share

  59. KHALIFA A, Sasso R, Rockey DC
    Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses.
    Dig Dis Sci. 2022;67:337-343.
    >> Share

  60. WANGRATTANAPRANEE P, Khrucharoen U, Jensen DM, Wongpongsalee T, et al
    Severe Upper Gastrointestinal Hemorrhage Caused by Reflux Esophagitis.
    Dig Dis Sci. 2022;67:159-169.
    >> Share

    December 2021
  61. JOHNSON KD, Perisetti A, Goyal H, Thandassery R, et al
    Liver Biopsy in Pregnancy: Two Case Reports and Review of the Literature.
    Dig Dis Sci. 2021;66:4090-4098.
    >> Share

  62. YAN Y, Xing X, Wang X, Men R, et al
    Development and Validation of an Easy-to-Use Risk Scoring System for Screening High-Risk Varices in Patients with HBV-Related Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2021;66:4518-4524.
    >> Share

  63. HIGUERA-DE-LA-TIJERA F, Cordova-Gallardo J, Buganza-Torio E, Barranco-Fragoso B, et al
    Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value.
    Dig Dis Sci. 2021;66:4501-4507.
    >> Share

  64. DHALIWAL HS, Singh R, Abraham AM, Sharma R, et al
    Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:4197-4207.
    >> Share

    November 2021
  65. CHANG JI, Sinn DH, Cho H, Kim S, et al
    Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07312.
    >> Share

  66. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
    Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
    >> Share

  67. PODRUG K, Trkulja V, Zelenika M, Bokun T, et al
    Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07277.
    >> Share

    Pressure Measurements Under Pressure: Simplifying the Diagnosis of Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07283.
    >> Share

  69. MANKA PP, Kaya E, Canbay A, Syn WK, et al
    A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:3676-3688.
    >> Share

  70. KOSICK HM, Keyrouz A, Adeyi O, Sebastiani G, et al
    A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:4046-4057.
    >> Share

  71. ABDU B, Akolkar S, Picking C, Boura J, et al
    Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2021;66:4035-4045.
    >> Share

    October 2021
  72. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
    Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
    Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
    >> Share

  73. LI W, Xue H, Li Y, Li P, et al
    HIPK3 Circular RNA Promotes Metastases of HCC Through Sponging miR-338-3p to Induce ZEB2 Expression.
    Dig Dis Sci. 2021;66:3439-3447.
    >> Share

  74. STINE JG, Soriano C, Schreibman I, Rivas G, et al
    Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:3604-3611.
    >> Share

    September 2021
  75. KONG J, Liang X, Zhang J, Zeng J, et al
    Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis.
    Dig Dis Sci. 2021 Sep 14. pii: 10.1007/s10620-021-07248.
    >> Share

  76. LI J, Lu M, Zhou Y, Bowlus CL, et al
    Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2021 Sep 9. pii: 10.1007/s10620-021-07219.
    >> Share

  77. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.
    >> Share

  78. LABENZ C, Kostev K, Kaps L, Galle PR, et al
    Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany.
    Dig Dis Sci. 2021;66:3179-3185.
    >> Share

  79. UFERE NN, Donlan J, Indriolo T, Richter J, et al
    Burdensome Transitions of Care for Patients with End-Stage Liver Disease and Their Caregivers.
    Dig Dis Sci. 2021;66:2942-2955.
    >> Share

    August 2021
  80. YOPES MC, Mozeika AM, Liebling S, Haslam A, et al
    An Analysis of 5 Years of Randomized Trials in Gastroenterology and Hepatology Reveals 52 Medical Reversals.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07199.
    >> Share

  81. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
    Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
    Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
    >> Share

  82. LOUISSAINT J, Kassab I, Yeboah-Korang A, Fontana RJ, et al
    Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.
    Dig Dis Sci. 2021 Aug 24. pii: 10.1007/s10620-021-07223.
    >> Share

  83. TRIVEDI HD, Niezen S, Jiang ZG, Tapper EB, et al
    Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
    Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07228.
    >> Share

  84. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
    Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
    >> Share

  85. ZHANG S, Tao X, Wang L, Chen H, et al
    Downregulation of Programmed Death-1 Pathway Promoting CD8 + T Cell Cytotoxicity in Primary Biliary Cholangitis.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07165.
    >> Share

  86. CHEN Y, Li H, Chen D, Jiang X, et al
    Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1alpha Expression.
    Dig Dis Sci. 2021 Aug 12. pii: 10.1007/s10620-021-07202.
    >> Share

  87. THAKER S, Mikolajczyk AE
    Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.
    >> Share

  88. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
    Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
    >> Share

  89. OH JH, Goh MJ, Park Y, Kim J, et al
    Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
    Dig Dis Sci. 2021;66:2816-2825.
    >> Share

  90. NOZAWA H, Emoto S, Sonoda H, Kawai K, et al
    Liver Injury Among Japanese Patients Treated Using Prophylactic Enoxaparin After Colorectal Surgery.
    Dig Dis Sci. 2021;66:2805-2815.
    >> Share

    July 2021
  91. BOCKORNY B, Bullock AJ, Abrams TA, Faintuch S, et al
    Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 Jul 23. pii: 10.1007/s10620-021-07156.
    >> Share

  92. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
    Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
    >> Share

  93. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
    Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
    >> Share

  94. BARNES EL, Grimm-Vavlitis JL, Long MD
    Impact of Virtual Interviews on Gastroenterology and Hepatology Fellowship Recruitment.
    Dig Dis Sci. 2021 Jul 15. pii: 10.1007/s10620-021-07123.
    >> Share

  95. LIU J, He X, Zou Y, Wang K, et al
    Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07054.
    >> Share

  96. MANKA P, Syn WK
    NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease.
    Dig Dis Sci. 2021;66:2147-2148.
    >> Share

  97. BOPPANA V, Sahni S, Glass J, Chang C, et al
    HCC You Cannot See.
    Dig Dis Sci. 2021;66:2185-2189.
    >> Share

  98. MARTIN M, Zou B, Hoang J, Jeong D, et al
    Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015.
    Dig Dis Sci. 2021;66:2240-2249.
    >> Share

    June 2021
  99. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
    Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
    >> Share

  100. CHAUHAN M, Zhang T, Thuluvath PJ
    Gender Differences in Liver Transplantation Outcomes in Polycystic Liver Disease.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07125.
    >> Share

  101. CANCADO GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, et al
    Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07122.
    >> Share

  102. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
    Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
    >> Share

  103. FRENETTE CT, Levy C, Saab S
    Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
    >> Share

  104. HA NB, Cho SJ, Mohamad Y, Kent D, et al
    Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
    >> Share

  105. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
    International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
    >> Share

  106. ZOU B, Yeo YH, Cheung R, Ingelsson E, et al
    Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank.
    Dig Dis Sci. 2021;66:2092-2100.
    >> Share

  107. SHARMA A, Keshava SN, Eapen A, Elias E, et al
    An Update on the Management of Budd-Chiari Syndrome.
    Dig Dis Sci. 2021;66:1780-1790.
    >> Share

    May 2021
  108. PENG X, Tian A, Li J, Mao Y, et al
    Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
    Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
    >> Share

  109. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    >> Share

  110. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    >> Share

  111. LI X, Lv J, Hou L, Guo X, et al
    Circ_0001955 Acts as a miR-646 Sponge to Promote the Proliferation, Metastasis and Angiogenesis of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 22. pii: 10.1007/s10620-021-07053.
    >> Share

  112. SERPER M
    Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
    >> Share

  113. YU B, Zhou S, Liang H, Ye Q, et al
    Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07031.
    >> Share

  114. ARTEEL GE, Singhvi A, Feldman R, Althouse AD, et al
    Coexistent Alcohol-Related Liver Disease and Alcohol-Related Pancreatitis: Analysis of a Large Heath Care System Cohort.
    Dig Dis Sci. 2021 May 7. pii: 10.1007/s10620-021-07010.
    >> Share

  115. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
    A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
    Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
    >> Share

  116. TO C, Liu L, Satoskar RS, Thuluvath PJ, et al
    Diabetic Hepatosclerosis in a Woman with Maturity-Onset Diabetes of the Young Type 3.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07005.
    >> Share

  117. RICH NE, Parvathaneni A, Sen A, Odewole M, et al
    High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07001.
    >> Share

  118. HASHIMOTO R, Lee DP, Samarasena JB, Chandan VS, et al
    Comparison of Two Specialized Histology Needles for Endoscopic Ultrasound (EUS)-Guided Liver Biopsy: A Pilot Study.
    Dig Dis Sci. 2021;66:1700-1706.
    >> Share

    April 2021
  119. SCHEWE J, Makeschin MC, Khandoga A, Zhang J, et al
    To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning.
    Dig Dis Sci. 2021;66:1349-1359.
    >> Share

  120. TROWELL J, Alukal J, Zhang T, Liu L, et al
    How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
    Dig Dis Sci. 2021;66:1297-1305.
    >> Share

  121. SINGAL AK, Ahmed Z, Axley P, Arora S, et al
    Hospitalizations for Acute on Chronic Liver Failure at Academic Compared to Non-academic Centers Have Higher Mortality.
    Dig Dis Sci. 2021;66:1306-1314.
    >> Share

    March 2021
  122. LIN RX, Zhan GF, Wu JC, Fang H, et al
    LncRNA SNHG14 Sponges miR-206 to Affect Proliferation, Apoptosis, and Metastasis of Hepatocellular Carcinoma Cells by Regulating SOX9.
    Dig Dis Sci. 2021 Mar 29. pii: 10.1007/s10620-021-06920.
    >> Share

  123. MAHMUD N, Asrani SK, Reese PP, Kaplan DE, et al
    Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Mar 24. pii: 10.1007/s10620-021-06943.
    >> Share

  124. LIN K, Huang Q, Zeng J, Ding Z, et al
    Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-020-06797.
    >> Share

  125. PERISETTI A, Goyal H
    Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.
    Dig Dis Sci. 2021 Mar 3. pii: 10.1007/s10620-021-06874.
    >> Share

    February 2021
  126. MIRAGLIA R, Maruzzelli L, Luca A
    Transjugular Intrahepatic Portosystemic Shunt: A Single-Centre Mid-term Experience Using the Viatorr Controlled-Expansion Stent.
    Dig Dis Sci. 2021 Feb 27. pii: 10.1007/s10620-021-06867.
    >> Share

  127. WANG X, Luo X, Yang L
    Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter.
    Dig Dis Sci. 2021 Feb 26. pii: 10.1007/s10620-021-06868.
    >> Share

  128. KANG N, Chung JW, Jang ES, Jeong SH, et al
    Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.
    Dig Dis Sci. 2021 Feb 25. pii: 10.1007/s10620-020-06762.
    >> Share

  129. XU YP, Dong ZN, Zhou YQ, Zhao YJ, et al
    Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.
    Dig Dis Sci. 2021 Feb 12. pii: 10.1007/s10620-021-06878.
    >> Share

  130. CHEN YC, Hsu CW, Jeng WJ, Lin CY, et al
    Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.
    Dig Dis Sci. 2021 Feb 10. pii: 10.1007/s10620-020-06761.
    >> Share

  131. BIE C, Chen Y, Tang H, Li Q, et al
    Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop.
    Dig Dis Sci. 2021 Feb 9. pii: 10.1007/s10620-021-06862.
    >> Share

  132. STERLING RK, King WC, Khalili M, Kleiner DE, et al
    Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06860.
    >> Share

  133. ZHANG D, Zhang Y, Zhang X, Zhai H, et al
    Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06861.
    >> Share

  134. NAM JY, Lee YB, Lee JH, Yu SJ, et al
    A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC.
    Dig Dis Sci. 2021 Feb 4. pii: 10.1007/s10620-021-06843.
    >> Share

  135. ZHOU SN, Pan WT, Pan MX, Luo QY, et al
    Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
    Dig Dis Sci. 2021;66:474-482.
    >> Share

  136. PATIDAR KR, Davis BC, Slaven JE, Ghabril MS, et al
    Admission Factor V Predicts Transplant-Free Survival in Acute Liver Failure.
    Dig Dis Sci. 2021;66:619-627.
    >> Share

    January 2021
  137. WU M, Jiang L
    Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 Jan 26. pii: 10.1007/s10620-021-06832.
    >> Share

  138. LI J, Bao S, Wang L, Wang R, et al
    CircZKSCAN1 Suppresses Hepatocellular Carcinoma Tumorigenesis by Regulating miR-873-5p/Downregulation of Deleted in Liver Cancer 1.
    Dig Dis Sci. 2021 Jan 13. pii: 10.1007/s10620-020-06789.
    >> Share

  139. ZHAO L, Ma N, Liu G, Mao N, et al
    Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06787.
    >> Share

  140. XU R, Yin S, Zheng M, Pei X, et al
    Circular RNA circZFR Promotes Hepatocellular Carcinoma Progression by Regulating miR-375/HMGA2 Axis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06805.
    >> Share

  141. TONTHAT A, Bui D, Romero M, Lo E, et al
    A Case of Benign Hepatic Cyst with Supra-elevated Cyst Fluid Tumor Markers.
    Dig Dis Sci. 2021 Jan 6. pii: 10.1007/s10620-020-06727.
    >> Share

  142. OU H, Liu Q, Lin J, He W, et al
    Pseudogene Annexin A2 Pseudogene 1 Contributes to Hepatocellular Carcinoma Progression by Modulating Its Parental Gene ANXA2 via miRNA-376a-3p.
    Dig Dis Sci. 2021 Jan 4. pii: 10.1007/s10620-020-06734.
    >> Share

  143. MACHADO P, Gupta I, Gummadi S, Stanczak M, et al
    Hepatic Vein Contrast-Enhanced Ultrasound Subharmonic Imaging Signal as a Screening Test for Portal Hypertension.
    Dig Dis Sci. 2021 Jan 4. pii: 10.1007/s10620-020-06790.
    >> Share

  144. BALDIN C, Piedade J, Guimaraes L, Victor L, et al
    CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients.
    Dig Dis Sci. 2021 Jan 3. pii: 10.1007/s10620-020-06791.
    >> Share

  145. HUANG Y, Chu P, Bao G
    Silencing of Long Non-coding RNA TTN-AS1 Inhibits Hepatocellular Carcinoma Progression by the MicroRNA-134/ITGB1 Axis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06737.
    >> Share

  146. HSU CY, Parikh ND, Huo TI, Tapper EB, et al
    Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06763.
    >> Share

  147. CAVAZZA A, McPhail MJ
    Absolutely FABulous? FABP-1 in Non-acetaminophen-related Acute Liver Failure.
    Dig Dis Sci. 2021;66:10-11.
    >> Share

  148. ABBASS A, Khalid S, Farooq U, Rakov N, et al
    If DILI Is Suspected, Don't Dally.
    Dig Dis Sci. 2021;66:52-55.
    >> Share

  149. PATEL HK, Saxena R, Rush N, Patel SK, et al
    A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?
    Dig Dis Sci. 2021;66:238-246.
    >> Share

  150. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
    Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction.
    Dig Dis Sci. 2021;66:273-283.
    >> Share

  151. KIM D, Yoo ER, Li AA, Tighe SP, et al
    Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
    Dig Dis Sci. 2021;66:296-307.
    >> Share

    December 2020
  152. BERGQUIST JR, Li AY, Chang EM, Scott GD, et al
    Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease.
    Dig Dis Sci. 2020;65:3482-3485.
    >> Share

  153. LI Q, Rempel JD, Ball TB, Aukema H, et al
    Plasma Oxylipins Levels in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3605-3613.
    >> Share

    November 2020
  154. KLOSTER ML, Ren A, Shah KY, Alqadi MM, et al
    High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Dig Dis Sci. 2020 Nov 24. pii: 10.1007/s10620-020-06716.
    >> Share

  155. O'LEARY JG, Rajender Reddy K, Tandon P, Biggins SW, et al
    Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06677.
    >> Share

  156. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
    Dig Dis Sci. 2020 Nov 5. pii: 10.1007/s10620-020-06695.
    >> Share

  157. BERGQUIST JR, Li AY, Javadi CS, Chima RS, et al
    Too Big to Fail: Successful Resection of a Large Hepatocellular Carcinoma with Portal Tumor Thrombus.
    Dig Dis Sci. 2020 Nov 3. pii: 10.1007/s10620-020-06682.
    >> Share

  158. ABY ES, Pham NV, Yum JJ, Dong TS, et al
    Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis.
    Dig Dis Sci. 2020 Nov 2. pii: 10.1007/s10620-020-06687.
    >> Share

  159. GREWAL J, Benhammou J, Patel PV, Saab S, et al
    Casting a Wider NET: An Unusual Cause of Acute Liver Failure in a Pregnant Patient.
    Dig Dis Sci. 2020;65:3102-3105.
    >> Share

  160. STINE JG, Xu D, Schmitz K, Sciamanna C, et al
    Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3238-3243.
    >> Share

  161. SINGH A, Amin H, Garg R, Gupta M, et al
    Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3341-3349.
    >> Share

  162. CHEN HW, Ferrando A, White MG, Dennis RA, et al
    Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
    Dig Dis Sci. 2020;65:3350-3359.
    >> Share

  163. ZHANG C, Wu Y, Yuan S, Dou X, et al
    Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types.
    Dig Dis Sci. 2020;65:3360-3368.
    >> Share

    October 2020
  164. WANG B, Zhao K, Hu W, Ding Y, et al
    Protective Mechanism of MIF Inhibitor ISO-1 on Intrahepatic Bile Duct Cells in Rats with Severe Acute Pancreatitis.
    Dig Dis Sci. 2020 Oct 29. pii: 10.1007/s10620-020-06674.
    >> Share

  165. CLARKE K, Bilal M, Sanchez-Luna SA, Dalessio S, et al
    Impact of COVID-19 Pandemic on Training: Global Perceptions of Gastroenterology and Hepatology Fellows in the USA.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06655.
    >> Share

  166. JI C, Hong X, Lan B, Lin Y, et al
    Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
    Dig Dis Sci. 2020 Oct 11. pii: 10.1007/s10620-020-06641.
    >> Share

  167. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
    Dig Dis Sci. 2020 Oct 9. pii: 10.1007/s10620-020-06630.
    >> Share

  168. ATHYROS VG, Katsiki N, Mikhailidis DP
    NAFLD and Statins.
    Dig Dis Sci. 2020;65:3052-3053.
    >> Share

  169. ZHANG Z, Yao W, Yuan D, Huang F, et al
    Effects of Connexin 32-Mediated Lung Inflammation Resolution During Liver Ischemia Reperfusion.
    Dig Dis Sci. 2020;65:2914-2924.
    >> Share

    September 2020
  170. NATARAJAN Y, Tansel A, Patel P, Emelogu IK, et al
    Correction to: Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06619.
    >> Share

  171. CHEN VL, Hawa F, Berinstein JA, Reddy CA, et al
    Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19.
    Dig Dis Sci. 2020 Sep 27. pii: 10.1007/s10620-020-06618.
    >> Share

  172. XIAO F, Gao M, Yang J, He L, et al
    FAM172A Deletion May Enhance Hepatic Steatosis by Promoting ER Stress.
    Dig Dis Sci. 2020 Sep 18. pii: 10.1007/s10620-020-06601.
    >> Share

  173. TRIEU H, Patel A, Wells C, Saab S, et al
    Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2020 Sep 14. pii: 10.1007/s10620-020-06582.
    >> Share

  174. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    >> Share

  175. SIMONS-LINARES CR, Abushamma S, Romero-Marrero C, Bhatt A, et al
    Clinical Outcomes of Acute Pancreatitis in Patients with Cirrhosis According to Liver Disease Severity Scores.
    Dig Dis Sci. 2020 Sep 6. pii: 10.1007/s10620-020-06575.
    >> Share

  176. SHAW J, Patidar KR, Reuter B, Hajezifar N, et al
    Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06583.
    >> Share

  177. PATEL A, Asch S, Antonio AL, Kanwal F, et al
    Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2020;65:2562-2570.
    >> Share

  178. SHALIMAR, Sharma S, Gamanagatti SR, Chauhan A, et al
    Acute-on-Chronic Liver Failure in Budd-Chiari Syndrome: Profile and Predictors of Outcome.
    Dig Dis Sci. 2020;65:2719-2729.
    >> Share

  179. AYYAGARI S, Tan MC, Liu Y, El-Serag HB, et al
    Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
    Dig Dis Sci. 2020;65:2691-2699.
    >> Share

    August 2020
  180. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    >> Share

  181. HYUN HK, Cho EJ, Park SY, Hong YM, et al
    Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
    Dig Dis Sci. 2020 Aug 28. pii: 10.1007/s10620-020-06533.
    >> Share

  182. PHAW NA, Dyson JK, Mells G, Jones D, et al
    Understanding Fatigue in Primary Biliary Cholangitis.
    Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
    >> Share

  183. REICHERT MC, Massmann A, Schulz A, Buecker A, et al
    Volume-Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE-A Feasibility Study.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06535.
    >> Share

  184. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
    Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
    Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.
    >> Share

  185. BALAKRISHNAN M, Seth A, Cortes-Santiago N, Jain S, et al
    External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06501.
    >> Share

  186. GRUTTADAURIA S, Pagano D, di Francesco F, Foglio A, et al
    Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06522.
    >> Share

  187. NATARAJAN Y, Tansel A, Patel P, Emologu K, et al
    Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Aug 2. pii: 10.1007/s10620-020-06498.
    >> Share

  188. PALETI S, Li Y, Okwara C, McCarthy D, et al
    Liver Abscess: A Wolf in Sheep's Clothing.
    Dig Dis Sci. 2020;65:2221-2224.
    >> Share

    July 2020
  189. BLOOM PP, Pasricha TS, Andersson KL, Pratt DS, et al
    Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management.
    Dig Dis Sci. 2020 Jul 29. pii: 10.1007/s10620-020-06495.
    >> Share

  190. CAO Y, Tao Q, Kao X, Zhu X, et al
    Hsa-circRNA-103809 Promotes Hepatocellular Carcinoma Development via MicroRNA-1270/PLAG1 Like Zinc Finger 2 Axis.
    Dig Dis Sci. 2020 Jul 18. pii: 10.1007/s10620-020-06416.
    >> Share

  191. JIANG L, Chu H, Gao B, Lang S, et al
    Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06461.
    >> Share

  192. LE L, Kullar R, Saleh HM, Saab S, et al
    Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06382.
    >> Share

  193. XIE X, Dou CY, Zhou Y, Zhou Q, et al
    MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06460.
    >> Share

  194. KOTWAL V, Mbachi C, Wang Y, Attar B, et al
    A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06456.
    >> Share

  195. AMJAD W, Alukal J, Zhang T, Maheshwari A, et al
    Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06437.
    >> Share

  196. MALLEPALLY N, Bilal M, Hernandez-Barco YG, Simons M, et al
    The New Virtual Reality: How COVID-19 Will Affect the Gastroenterology and Hepatology Fellowship Match.
    Dig Dis Sci. 2020 Jul 1. pii: 10.1007/s10620-020-06432.
    >> Share

  197. MORNINGSTAR JE, Syn WK, Litwin SE
    The Emerging Epidemic of Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: True, True, and Related?
    Dig Dis Sci. 2020;65:1885-1887.
    >> Share

  198. SHRESTHA MP, Senussi N, Volpicelli N, McCarthy D, et al
    Tangled Up in Red Cells: A Large Liver Mass with Intravascular Hemolysis.
    Dig Dis Sci. 2020;65:1960-1963.
    >> Share

  199. LABENZ C, Huber Y, Michel M, Nagel M, et al
    Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.
    Dig Dis Sci. 2020;65:2112-2119.
    >> Share

    June 2020
  200. YUE W, Liu Y, Jiang W, Huang J, et al
    Prealbumin and D-dimer as Prognostic Indicators for Rebleeding in Patients with Nonvariceal Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2020 Jun 24. pii: 10.1007/s10620-020-06420.
    >> Share

  201. LOUISSAINT J, Foster C, Harding-Theobald E, Lok AS, et al
    Social Support Does Not Modify the Risk of Readmission for Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2020 Jun 23. pii: 10.1007/s10620-020-06421.
    >> Share

  202. GOTO T, Selzner M
    Low-Pressure Tactic: A Novel Intrahepatic Shunt Improves Outcomes in Experimental Small-for-Size Syndrome.
    Dig Dis Sci. 2020 Jun 18. pii: 10.1007/s10620-020-06385.
    >> Share

  203. KEGASAWA T, Sakamori R, Maesaka K, Yamada R, et al
    Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Jun 17. pii: 10.1007/s10620-020-06380.
    >> Share

  204. HO SY, Hsu CY, Liu PH, Lee RC, et al
    Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Dig Dis Sci. 2020 Jun 16. pii: 10.1007/s10620-020-06384.
    >> Share

  205. DANFORD CJ, Lee JY, Strohbehn IA, Corey KE, et al
    Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06388.
    >> Share

  206. LONG MD, Raffals L, Williams R
    Program Directors' Perspectives of Gastroenterology and Hepatology Fellowship Application.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06378.
    >> Share

  207. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
    Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
    >> Share

  208. BARAKAT MT, Josephs S, Gugig R
    Return to Native Drainage: Duodenal Biliary Fistula Formation Following Pediatric Hepatobiliary Surgery with Roux-en-Y Reconstruction.
    Dig Dis Sci. 2020 Jun 12. pii: 10.1007/s10620-020-06372.
    >> Share

  209. SHIN JW, Jeong J, Jung SW, Lee SB, et al
    Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
    Dig Dis Sci. 2020 Jun 10. pii: 10.1007/s10620-020-06375.
    >> Share

  210. TERBAH R, Gow P, Sinclair M, Testro A, et al
    Terlipressin for Type 1 Hepatorenal Syndrome.
    Dig Dis Sci. 2020 Jun 8. pii: 10.1007/s10620-020-06370.
    >> Share

  211. WANG CW, Lebsack A, Sudore RL, Lai JC, et al
    Low Rates of Advance Care Planning (ACP) Discussions Despite Readiness to Engage in ACP Among Liver Transplant Candidates.
    Dig Dis Sci. 2020 Jun 4. pii: 10.1007/s10620-020-06369.
    >> Share

  212. LONARDO A, Targher G
    Cardiovascular Risk in NAFLD: An Intimate Relationship?
    Dig Dis Sci. 2020;65:1593-1595.
    >> Share

  213. SHAO C, Ye J, Li F, Lin Y, et al
    Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients.
    Dig Dis Sci. 2020;65:1850-1860.
    >> Share

    May 2020
  214. KHOKHAR MA, O'Beirne J
    Transjugular Intrahepatic Portosystemic Shunts for Hepatorenal Syndrome: TIPping the Scales in Whose Favor?
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06351.
    >> Share

  215. SHROFF H, Rinella ME
    Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
    >> Share

  216. LUI FH, Ma P, Helmy M, Hu KQ, et al
    Ultrasonographic (US) Two-Dimensional Measurement of Spleen Is Superior to Traditional Length Measurement Alone in Diagnosing Cirrhosis.
    Dig Dis Sci. 2020 May 23. pii: 10.1007/s10620-020-06332.
    >> Share

  217. CHAHAL D, Yoshida EM, Arbour L, Wallach JP, et al
    Post-partum Primary Biliary Cholangitis Preceded by Intrahepatic Cholestasis of Pregnancy in Three First Nation Patients.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06333.
    >> Share

  218. NAGAOKA K, Ogawa K, Ji C, Cao KY, et al
    Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06330.
    >> Share

  219. FERRARESE A, Burra P, Senzolo M
    A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06278.
    >> Share

  220. FAHAD H, Sarmini MT, Modaresi-Esfeh J
    Does Obesity Affect Outcomes of Transjugular Intrahepatic Portosystemic Shunt Placement?
    Dig Dis Sci. 2020 May 6. pii: 10.1007/s10620-020-06276.
    >> Share

  221. CHEN X, Liu C, Ruan L
    G-Protein-Coupled Receptors 120 Agonist III Improves Hepatic Inflammation and ER Stress in Steatohepatitis.
    Dig Dis Sci. 2020 May 5. pii: 10.1007/s10620-020-06280.
    >> Share

  222. IZZY M, Shingina A
    Functional Status and Liver Disease Phenotype: Frailty, Thy Presence Is Ominous.
    Dig Dis Sci. 2020;65:1296-1298.
    >> Share

  223. MUKTHINUTHALAPATI VVPK, Attar BM, Parra-Rodriguez L, Cabrera NL, et al
    Risk Factors, Management, and Outcomes of Pyogenic Liver Abscess in a US Safety Net Hospital.
    Dig Dis Sci. 2020;65:1529-1538.
    >> Share

    April 2020
  224. ZHANG G, Ma J, Xiong J, Huang X, et al
    Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 29. pii: 10.1007/s10620-020-06277.
    >> Share

  225. LIU GM, Zeng HD, Zhang CY, Xu JW, et al
    Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 24. pii: 10.1007/s10620-020-06260.
    >> Share

  226. ACHARYA C, White MB, Fagan A, Sterling RK, et al
    Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
    >> Share

  227. EL-SERAG HB, Sardell R, Thrift AP, Kanwal F, et al
    Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA.
    Dig Dis Sci. 2020 Apr 17. pii: 10.1007/s10620-020-06231.
    >> Share

  228. BLOOM PP
    A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06251.
    >> Share

  229. TESTINO G
    Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06243.
    >> Share

  230. MOCTEZUMA-VELAZQUEZ C, Montano-Loza AJ, Meza-Junco J, Burak K, et al
    Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages.
    Dig Dis Sci. 2020 Apr 12. pii: 10.1007/s10620-020-06245.
    >> Share

  231. SUN RF, Zhao CY, Chen S, Yu W, et al
    Androgen Receptor Stimulates Hexokinase 2 and Induces Glycolysis by PKA/CREB Signaling in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 9. pii: 10.1007/s10620-020-06229.
    >> Share

  232. TURKSEVEN S, Bolognesi M, Di Pascoli M
    Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis.
    Dig Dis Sci. 2020 Apr 2. pii: 10.1007/s10620-020-06233.
    >> Share

  233. TIEN PC, Duarte M, Roque A, Price J, et al
    MRE and ELF in Liver Fibrosis Assessment: Are Two Better Than One?
    Dig Dis Sci. 2020;65:928-930.
    >> Share

  234. SHERIF ZA
    Unmasking a Stealth Killer: The Need for Increased Awareness of NASH.
    Dig Dis Sci. 2020;65:987-989.
    >> Share

  235. KAPLAN DE
    A Matter of TACEte: Plain Vanilla or Combination?
    Dig Dis Sci. 2020;65:934-936.
    >> Share

  236. DIPAOLA F, Trout AT, Walther AE, Gupta A, et al
    Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes.
    Dig Dis Sci. 2020;65:1239-1251.
    >> Share

  237. SINGH A, Dhaliwal AS, Singh S, Kumar A, et al
    Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort.
    Dig Dis Sci. 2020;65:978-986.
    >> Share

    March 2020
  238. ZORI A, Villanueva F, Hatamleh D, Ismael M, et al
    Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial.
    Dig Dis Sci. 2020 Mar 26. pii: 10.1007/s10620-020-06201.
    >> Share

  239. WANG C, Luo J, Chen Z, Ye M, et al
    MiR-375 Impairs the Invasive Capabilities of Hepatoma Cells by Targeting HIF1alpha Under Hypoxia.
    Dig Dis Sci. 2020 Mar 25. pii: 10.1007/s10620-020-06202.
    >> Share

  240. SHAMA S, Liu W
    Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:906-910.
    >> Share

  241. LECHNER S, Yee M, Limketkai BN, Pham EA, et al
    Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction.
    Dig Dis Sci. 2020;65:897-905.
    >> Share

    February 2020
    Liver Transplantation for Alcoholic Liver Disease: What Is the Risk and Consequence of Relapse?
    Dig Dis Sci. 2020 Feb 14. pii: 10.1007/s10620-020-06127.
    >> Share

    January 2020
  243. LU J, Wang H, Zhang R, Wan Z, et al
    Effects of Photoperiod on Acetaminophen-Induced Hepatotoxicity in Mice.
    Dig Dis Sci. 2020;65:178-188.
    >> Share

  244. MILES DA, Levi CS, Uhanova J, Cuvelier S, et al
    Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the Liver.
    Dig Dis Sci. 2020;65:82-85.
    >> Share

    December 2019
  245. KAPS L, Grambihler A, Yemane B, Nagel M, et al
    Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
    Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06009.
    >> Share

    November 2019
  246. DEUTSCH-LINK S, Weinrieb RM, Jones LS, Solga SF, et al
    Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation.
    Dig Dis Sci. 2019 Nov 9. pii: 10.1007/s10620-019-05937.
    >> Share

  247. SIMMONS OL, Meinzer C, Rule J, Lee WM, et al
    Liver Transplantation for Acetaminophen-Induced Acute Liver Failure: Role of Psychiatric Comorbidity in Listing Decisions and Outcomes.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05901.
    >> Share

    October 2019
  248. MCCABE P, Galoosian A, Wong RJ
    Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
    Dig Dis Sci. 2019 Oct 22. pii: 10.1007/s10620-019-05891.
    >> Share

    September 2019
  249. GALOOSIAN A, Hanlon C, Tana M, Cheung R, et al
    Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05809.
    >> Share

    August 2019
  250. HAO YL, Bian ZL, Ju LL, Liu Y, et al
    RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
    Dig Dis Sci. 2019 Aug 3. pii: 10.1007/s10620-019-05758.
    >> Share

    July 2019
  251. KUZNIETSOVA HM, Dziubenko NV, Lynchak OV, Herheliuk TS, et al
    Effects of Pristine C60 Fullerenes on Liver and Pancreas in alpha-Naphthylisothiocyanate-Induced Cholangitis.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05730.
    >> Share

    May 2019
  252. TU W, Gong J, Tian D, Wang Z, et al
    Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis.
    Dig Dis Sci. 2019 May 30. pii: 10.1007/s10620-019-05681.
    >> Share

    April 2019
  253. KALANI A, Phan J, Taefi A, Deshmukh M, et al
    Necrotizing Pancreatitis: Common and Uncommon Sequelae and Solutions.
    Dig Dis Sci. 2019 Apr 27. pii: 10.1007/s10620-019-05634.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016